Bone Biologics Corp
BBLG
Get informed when a big investor buys or sells
+ FollowMarket Cap$997.16K
Close$
$2.19
297.9% upside
Current Fair Value
297.9% upsideUndervalued by 297.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $997,157.00 |
|---|---|
| Enterprise Value | $-3,034,623.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.65 |
| Beta | 0.5 |
| Outstanding Shares | 1,796,755 |
Return
| Return on Equity | -73.66% |
|---|---|
| Return on Assets | -65.16% |
| Return on Invested Capital | -75.34% |
Valuation & Multiples
| P/E Ratio | -0.3 |
|---|---|
| PEG | -6.61 |
| Price to Sales | - |
| Price to Book Ratio | 0.28 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 1.03 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.43
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.45%▲ 1.20% |
|---|---|
| Total Invested | $35,705▲ 635.58% |
| Investors Holding | 30% |
ESG Score
No data
About Bone Biologics Corp
2 employees